Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095)-Reference-Cited by-同舟云学术

Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095)

Published:2010-08-20 Issue:8 Volume:127 Page:1813-1822
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sotomayor Sandra,Muñoz-Moreno Laura,Carmena María J.,Schally Andrew V.,Sánchez-Chapado Manuel,Prieto Juan C.,Bajo Ana M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. New therapeutic concepts in prostate cancer;Hamdy;BJU Int,2001

3. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin;Schally;Life Sci,2003

4. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers;Sun;Regul Pept,2000

5. Bombesin-related peptides and their receptors. Recent advances in their role in physiology and disease states;González;Curr Opin Endocrinol Diabetes Obes,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and applications of peptide–agent conjugates for targeting tumor cells;Journal of Cancer Research and Clinical Oncology;2023-08-15

2. Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023

3. Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?;Chemical Biology & Drug Design;2022-11-21

4. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives;Applied Sciences;2022-09-07

5. Peptide-based targeted cancer therapeutics: Design, synthesis and biological evaluation;European Journal of Pharmaceutical Sciences;2022-09